American International Group, Inc. Applied Therapeutics Inc. Transaction History

American International Group, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.76 - $2.64 $6,682 - $23,213	-8,793 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.48 - $6.22 $917 - $3,856	-620 Reduced 6.59%	8,793 $19,000
Q4 2021 Feb 11, 2022	SELL	$8.77 - $18.29 $2,464 - $5,139	-281 Reduced 2.9%	9,413 $84,000
Q3 2021 Nov 12, 2021	SELL	$13.54 - $22.06 $3,127 - $5,095	-231 Reduced 2.33%	9,694 $161,000
Q2 2021 Aug 13, 2021	BUY	$14.05 - $25.04 $12,659 - $22,561	901 Added 9.98%	9,925 $206,000
Q1 2021 May 07, 2021	BUY	$16.57 - $28.65 $18,293 - $31,629	1,104 Added 13.94%	9,024 $169,000
Q4 2020 Feb 12, 2021	SELL	$15.44 - $24.23 $3,504 - $5,500	-227 Reduced 2.79%	7,920 $174,000
Q3 2020 Nov 04, 2020	SELL	$19.43 - $35.36 $252 - $459	-13 Reduced 0.16%	8,147 $169,000
Q2 2020 Aug 12, 2020	BUY	$29.41 - $51.23 $98,258 - $171,159	3,341 Added 69.33%	8,160 $295,000
Q1 2020 May 04, 2020	BUY	$19.54 - $55.47 $15,827 - $44,930	810 Added 20.2%	4,819 $158,000
Q4 2019 Feb 05, 2020	BUY	$10.16 - $28.14 $27,787 - $76,962	2,735 Added 214.68%	4,009 $109,000
Q3 2019 Nov 08, 2019	BUY	$8.08 - $10.99 $10,293 - $14,001	1,274 New	1,274 $14,000

140

112M

1.68M

1.91M

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $41.8M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.